Back | Next |
home / stock / aqxp / aqxp message board
Subject | By | Source | When |
---|---|---|---|
she is ready for a huge squeeze. Get | aristotelisonassis | investorshub | 07/17/2018 7:40:27 PM |
Next week we will be above 3.00 | ZLAZARUS | investorshub | 07/07/2018 2:00:06 AM |
In at 2.51 .. thank you for the alert | ZLAZARUS | investorshub | 07/02/2018 1:35:07 PM |
$4. | TheAnnointedOne | investorshub | 07/01/2018 11:15:40 PM |
I see it being worth $3.50 bare minimum. | ZLAZARUS | investorshub | 07/01/2018 11:03:34 PM |
Have $100m in the books. Oversold. I believe | TheAnnointedOne | investorshub | 07/01/2018 10:57:57 PM |
Just found this one, thinking about getting in | ZLAZARUS | investorshub | 07/01/2018 10:43:28 PM |
Panic sells, bouncing back healthily now. | TheAnnointedOne | investorshub | 07/01/2018 5:29:37 PM |
Looks way over sold | ZLAZARUS | investorshub | 06/30/2018 6:26:07 AM |
* * $AQXP Video Chart 06-29-18 * * | ClayTrader | investorshub | 06/29/2018 9:13:49 PM |
Going up, sit back for the long ride | airahim | investorshub | 06/29/2018 7:38:25 PM |
Back over $5 soon, market overreacted. Price will | TheAnnointedOne | investorshub | 06/29/2018 6:07:05 PM |
I.am.just cracking up now....12500 shares. 8500 at roughly | keekee | investorshub | 06/28/2018 6:07:18 PM |
Looking good there! | TheAnnointedOne | investorshub | 06/28/2018 4:30:04 PM |
Yep. I bot 4k more at $2.17. This | keekee | investorshub | 06/28/2018 2:56:45 PM |
Wow, great entry point. | TheAnnointedOne | investorshub | 06/28/2018 2:26:40 PM |
So far as I know, the dollar has | keekee | investorshub | 06/28/2018 2:25:19 PM |
Bought 8500 at $2.03/$1.99. We will see | keekee | investorshub | 06/28/2018 2:22:55 PM |
Aquinox says results support halting all further development | 420man | investorshub | 06/28/2018 12:05:59 PM |
Nearly 100m cash on hand. Great bottom imo. | TheAnnointedOne | investorshub | 06/28/2018 11:27:41 AM |
News, Short Squeeze, Breakout and More Instantly...
Aquinox Pharmaceuticals Inc. Company Name:
AQXP Stock Symbol:
NASDAQ Market:
Aquinox Pharmaceuticals Inc. Website:
Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein...
SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, and Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP),...
• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/IL-15 agonist with favorable t...